Corient Private Wealth’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63M Buy
686,792
+191,000
+39% +$16.7M 0.08% 215
2026
Q1
$41.8M Sell
495,792
-829,246
-63% -$73.9M 0.06% 265
2025
Q4
$85.1M Buy
1,325,038
+848,854
+178% +$66.6M 0.06% 270
2025
Q3
$38.1M Sell
476,184
-59,389
-11% -$5.07M 0.06% 272
2025
Q2
$48.7M Buy
535,573
+3,346
+0.6% +$305K 0.06% 236
2025
Q1
$49.9M Sell
532,227
-66,243
-11% -$5.93M 0.08% 221
2024
Q4
$54.1M Buy
598,470
+52,390
+10% +$5M 0.09% 211
2024
Q3
$56.7M Sell
546,080
-7,972
-1% -$813K 0.09% 217
2024
Q2
$53.8M Buy
554,052
+8,321
+2% +$768K 0.09% 217
2024
Q1
$49.1M Buy
545,731
+1,800
+0.3% +$153K 0.09% 221
2023
Q4
$43.4M Buy
543,931
+6,420
+1% +$483K 0.08% 240
2023
Q3
$38.2M Buy
537,511
+17,264
+3% +$1.29M 0.09% 240
2023
Q2
$40.1M Sell
520,247
-9,666
-2% -$748K 0.09% 220
2023
Q1
$39.8M Buy
529,913
+222,787
+73% +$16.6M 0.11% 186
2022
Q4
$24.2M Buy
+307,126
New +$23M 0.09% 243

Other funds holding CL

Corient Private Wealth's CL Position: Q2 2026 in Review

Corient Private Wealth increased its Colgate-Palmolive (CL) stake by 39% in Q2 2026, buying an estimated $16.7M and bringing the position to 686,792 shares worth $63M. The position accounts for 0.08% of the portfolio, ranked #215.

Corient Private Wealth first reported a position in CL in Q4 2022 and has held it in 15 quarters since. The position peaked at $85.1M in Q4 2025. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Corient Private Wealth held 686,792 shares of Colgate-Palmolive worth $63M as of Q2 2026.
  • Corient Private Wealth bought 191,000 Colgate-Palmolive shares in Q2 2026, an estimated $16.7M.
  • Colgate-Palmolive made up 0.08% of Corient Private Wealth's portfolio in Q2 2026, its #215 holding.
  • Corient Private Wealth first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Colgate-Palmolive position peaked at $85.1M in Q4 2025.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.